Download full-text PDF

Source
http://dx.doi.org/10.1136/vr.157.24.782DOI Listing

Publication Analysis

Top Keywords

re-emerging risk
4
risk hydatid
4
hydatid disease
4
disease wales
4
re-emerging
1
hydatid
1
disease
1
wales
1

Similar Publications

Crimean Congo hemorrhagic fever (CCHF) is a re-emerging tick-borne zoonosis that is caused by CCHF virus (CCHFV). The geographical distribution of the disease and factors that influence its occurrence are poorly known. We analysed historical records on its outbreaks in various countries across the sub-Saharan Africa (SSA) to identify hotspots and determine socioecological and demographicfactors associated with these outbreaks.

View Article and Find Full Text PDF

Exploring survival rates in HIV-infected Ethiopian children receiving HAART: a retrospective cohort study.

BMJ Paediatr Open

January 2025

Research Center on Global Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease, Universitas Airlangga, Surabaya, 60115, Indonesia

Background: Studies have shown a high rate of mortality among adults despite the introduction of highly active antiretroviral therapy (HAART). However, long-term outcomes of HAART among children remain poorly documented in Ethiopia. This study aimed to estimate the survival rate and identify associated factors among HIV-infected children on antiretroviral therapy.

View Article and Find Full Text PDF

Viral infections of the central nervous system (CNS) have been emerging and re-emerging worldwide, and the Australasia region has not been spared. Enterovirus A71 and enterovirus D68, both human enteroviruses, are likely to replace the soon-to-be eradicated poliovirus to cause global outbreaks associated with neurological disease. Although prevalent elsewhere, the newly emergent orthoflavivirus, Japanese encephalitis virus (genotype IV), caused human infections in Australia in 2021, and almost certainly will continue to do so because of spillovers from the natural animal host-vector life cycle endemic in the country.

View Article and Find Full Text PDF

Putting governance into practice: The engagement of private health sector for Universal Health Coverage and health security.

East Mediterr Health J

December 2024

Assistant Director-General of the Universal Health Coverage, Life Course Division, World Health Organization Headquarters, Geneva.

The 'next pandemic' has become a common terminology increasingly used in media and academic literature. Emerging pathogens pose a considerable risk to our increasingly globalised communities and there is a need for adequate preparedness for them. However, in Lebanon, like in many countries, the 'next' pathogens, such as the measles pathogen, posing a dire threat to public health are neither emerging nor re-emerging; they are common, endemic and vaccine-preventable.

View Article and Find Full Text PDF

The emergence and re-emergence of multi-drug-resistant (MDR) infectious diseases have once again posed a significant global health challenge, largely attributed to the development of bacterial resistance to conventional anti-microbial treatments. To mitigate the risk of drug resistance globally, both antibiotics and immunotherapy are essential. Antimicrobial peptides (AMPs), also referred to as host defense peptides (HDPs), present a promising therapeutic alternative for treating drug-resistant infections due to their various mechanisms of action, which encompass antimicrobial and immunomodulatory effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!